Singapore markets close in 9 minutes
  • Straits Times Index

    3,291.16
    -3.66 (-0.11%)
     
  • Nikkei

    27,522.26
    -250.67 (-0.90%)
     
  • Hang Seng

    24,965.55
    +13.20 (+0.05%)
     
  • FTSE 100

    7,508.30
    -76.71 (-1.01%)
     
  • BTC-USD

    39,109.88
    -2,813.19 (-6.71%)
     
  • CMC Crypto 200

    924.65
    -70.61 (-7.09%)
     
  • S&P 500

    4,482.73
    -50.03 (-1.10%)
     
  • Dow

    34,715.39
    -313.26 (-0.89%)
     
  • Nasdaq

    14,154.02
    -186.23 (-1.30%)
     
  • Gold

    1,832.20
    -10.40 (-0.56%)
     
  • Crude Oil

    83.77
    -1.78 (-2.08%)
     
  • 10-Yr Bond

    1.8330
    0.0000 (0.00%)
     
  • FTSE Bursa Malaysia

    1,523.29
    -4.46 (-0.29%)
     
  • Jakarta Composite Index

    6,726.37
    +99.50 (+1.50%)
     
  • PSE Index

    7,293.52
    +54.24 (+0.75%)
     
DEALS:

Singtel takes 16.3% stake in Indonesia's Bank Fama for S$48 million

CDMO Market to Reach USD 278.98 Billion by 2026 | CDMO Industry Size, Share, Growth Factors, Trends, Forecast

·4-min read

Key Prominent Players Covered in the CDMO Market are Catalent, Inc , Baxter, Vetter, Recipharm AB, Albany Molecular Research Inc. (AMRI), Thermo Fisher Scientific Inc. (Patheon), Unither, DPT LABORATORIES LTD., NextPharma Technologies, Others.

Pune, India, Nov. 29, 2021 (GLOBE NEWSWIRE) -- The global “CDMO Market” size is projected to reach USD 278.98 billion by the end of 2026. Mergers and acquisitions are a growing trend among major companies across the world. According to a report published by Fortune Business Insights, titled “Contract Development and Manufacturing Organization (CDMO) Market Size, Share & Industry Analysis, By Service {By CMO (API, Finished Product {Solid Dosage Forms, Injectables, and Others}, and Packaging)} {By CRO (Discovery, Preclinical, Clinical Trial, and Laboratory Services)} and Regional Forecast, 2019-2026,” the market was worth USD 130.80 billion in 2018 and will exhibit a CAGR of 10.0% during the forecast period, 2019-2026.

Industry Developments:

February 2019: Jubilant Biosys collaborated with Sanofi to develop small molecule inhibitors for in the CNS therapeutic area.


Request a Sample Copy of the Research Report

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/contract-development-and-manufacturing-organization-cdmo-outsourcing-market-102502


Report Overview:

The CDMO Market is segmented on the basis of factors such as service and geographies. The report provides forecast values for the market for the period of 2019-2026. The factual figures have been obtained through trusted sources. Moreover, these predictions are made on the basis of extensive research analysis methods, coupled with the opinions of experienced market research professionals. The report highlights the latest product launches and labels major innovations in the market. In addition to this, it states the impact of these products on the growth of the market. The competitive landscape has been discussed in detail and predictions are made with respect to leading companies and products in the coming years.


Click here to get the short-term and long-term impact of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/contract-development-and-manufacturing-organization-cdmo-outsourcing-market-102502


Recipharm AB Introduces New Fully Integrated Service Platform

Accounting to the huge potential held by CDMOs, several companies are looking to invest more in the development of newer products. The huge investments have yielded a few exceptional products in recent years. In May 2019, Recipharm AB announced the launch of a fully integrated service platform for inhalation products. This will include the early stages of the products including the pre-clinical trials to the commercialization of the products. Recipharm’s latest product will generate huge sales and subsequently high revenues for the company. This will not just benefit the company, but will have a positive impact on the growth of the overall market in the coming years.

Asia Pacific to Register Highest CAGR; Increasing Company Collaborations Will Aid Growth of the Regional Market

The report analyses the ongoing CDMO market trends across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Among these regions, the market in Asia Pacific will register the highest CAGR in the coming years driven by the increasing number of company collaborations and mergers in several countries across the world. The market in North America is projected to emerge dominant in the coming years, owing to the presence of several well-established companies. As of 2018, the market in North America was worth USD 48.72 billion in 2018 and this value is projected to increase further in the coming years.


Quick Buy CDMO Market

https://www.fortunebusinessinsights.com/checkout-page/102502


List of companies profiled in the report:

  • Catalent, Inc

  • Baxter

  • Vetter

  • Recipharm AB

  • Albany Molecular Research Inc. (AMRI)

  • Thermo Fisher Scientific Inc. (Patheon)

  • Unither

  • DPT LABORATORIES LTD.

  • NextPharma Technologies

  • Others


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.


Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:sales@fortunebusinessinsights.com

LinkedIn | Twitter | Blogs


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting